iCarTAB BioMed Inc.   Report issue

For profit Phase 2
Founded: Suzhou China (2015)

Organization Overview

First Clinical Trial
2016
NCT02782351
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now